Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amino Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN112852894A reveals SpAmDH mutant for high-purity chiral amino alcohol. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN107021884A reveals high-efficiency Ir/f-amphox catalysis for chiral 1,2-amino alcohols, offering superior TON and enantioselectivity for pharmaceutical manufacturing.
Patent CN104418775B details palladium-catalyzed asymmetric hydrogenolysis for high-purity chiral amine production offering significant supply chain and cost advantages.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Patent CN115043775B reveals a novel chiral pyridoxal catalyst enabling biomimetic aldol reactions for beta-amino alcohol synthesis with high enantioselectivity and scalable manufacturing potential.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN113322291A details an enzymatic route for high-purity chiral amino alcohols, offering cost-effective solutions for veterinary antibiotic manufacturing.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Patent CN115160162A details an iridium-catalyzed method for synthesizing chiral beta-hydroxy alpha-amino acid derivatives with high enantioselectivity, offering significant cost reduction in API manufacturing.
Patent CN116102464B details asymmetric hydrogenation for high-purity chiral amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Analysis of patent CN105130842B reveals a novel heterogeneous catalyst for chiral amino alcohol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101591250A details a streamlined one-step Mannich synthesis and tartaric acid resolution for high-purity chiral amino alcohol ligands, offering significant cost and supply chain advantages.
Novel Ni-catalyzed asymmetric method for chiral quaternary carbon alpha-amino acid esters. High yield, excellent ee, scalable process for API intermediates.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.